L'hépatite virale B, une grande endémie planétaire = Viral hepatitis B, a world-wide endemySERFATY, L.Médecine et hygiène. 1992, Vol 50, Num 1951, pp 2705-2710, issn 0025-6749, 4 p.Article

Modes de transmission non transfusionnelle et non par toxicomanie intra-veineuse du VHC = Non-transfusional and non-intravenous drug abuse transmission of hepatitis C virusSERFATY, L.La Presse médicale (1983). 1999, Vol 28, Num 21, pp 1135-1140, issn 0755-4982Article

Therapeutic approaches of hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivativesSERFATY, L.Clinics and research in hepatology and gastroenterology (Print). 2012, Vol 36, issn 2210-7401, 65 p., SUP1Serial Issue

Place, rôle et spécificité de l'hospitalisation privéeSERFATY, L.Revue politique et parlementaire. 1999, Num 998, pp 98-101, issn 0035-385XArticle

Progressive familial intrahepatic cholestasisJACQUEMIN, Emmanuel.Clinics and research in hepatology and gastroenterology (Print). 2012, Vol 36, issn 2210-7401, S26-S35, SUP1Article

Chemoprevention of colorectal cancer with ursodeoxycholic acid: ProSERFATY, Lawrence.Clinics and research in hepatology and gastroenterology (Print). 2012, Vol 36, issn 2210-7401, S53-S60, SUP1Article

Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: An overview of their mechanisms of actionPOUPON, Raoul.Clinics and research in hepatology and gastroenterology (Print). 2012, Vol 36, issn 2210-7401, S3-S12, SUP1Article

Prophylaxie et traitement de l'hépatite C = Prophylaxis and treatment of hepatitis CPOUPON, R; SERFATY, L.Annales de gastroénterologie et d'hépatologie. 1997, Vol 33, Num 1, pp 34-38, issn 0066-2070Article

Primary biliary cirrhosis and bile acidsCORPECHOT, Christophe.Clinics and research in hepatology and gastroenterology (Print). 2012, Vol 36, issn 2210-7401, S13-S20, SUP1Article

Primary sclerosing cholangitis and bile acidsCHAZOUILLERES, Olivier.Clinics and research in hepatology and gastroenterology (Print). 2012, Vol 36, issn 2210-7401, S21-S25, SUP1Article

Low phospholipid-associated cholestasis and cholelithiasisERLINGER, Serge.Clinics and research in hepatology and gastroenterology (Print). 2012, Vol 36, issn 2210-7401, S36-S40, SUP1Article

Treatment of NASH with ursodeoxycholic acid: ProRATZIU, Vlad.Clinics and research in hepatology and gastroenterology (Print). 2012, Vol 36, issn 2210-7401, S41-S45, SUP1Article

Ursodeoxycholic acid and chemoprevention of colorectal cancerSERFATY, L; BISSONNETTE, M; POUPON, R et al.Gastroentérologie clinique et biologique. 2010, Vol 34, Num 10, pp 516-522, issn 0399-8320, 7 p.Article

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C . CommentaryZEKRY, A; MCHUTCHISON, J. G; DIEHL, A. M et al.Gut. 2005, Vol 54, Num 7, pp 903-906, issn 0017-5749, 10 p.Article

Ictère cholestatique induit par la prise d'acide fucidique chez un patient cirrhotique = Cholestatic icterus induced by administration of fucidic acid in a cirrhotic ptientCARBONELL, N; TBABUT, D; PODEVIN, P et al.La Presse médicale (1983). 2002, Vol 31, Num 23, pp 1083-1084, issn 0755-4982Article

Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activitySERFATY, L; CHAZOUILLERES, O; PAWLOTSKY, J.-M et al.Gastroenterology (New York, NY. 1943). 1996, Vol 110, Num 1, pp 291-295, issn 0016-5085Article

Alcool, stéatohépatite métabolique, insulinorésistance et hépatite C = Alcohol, steatohepatitis, insulino-resistance and hepatitis CCOUZIGOU, P; MATHURIN, P; SERFATY, L et al.Gastroentérologie clinique et biologique. 2008, Vol 32, Num 3, issn 0399-8320, S74-S81, CAH2Article

Definition and natural history of metabolic steatosis : clinical aspects of NAFLD, NASH and cirrhosisSERFATY, L; LEMOINE, M.Diabetes & metabolism. 2008, Vol 34, Num 6, pp 634-637, issn 1262-3636, 4 p., 2Conference Paper

Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferonPOUPON, R. E; BONNAND, A.-M; CAPRON, J.-P et al.Scandinavian journal of gastroenterology. 2000, Vol 35, Num 6, pp 642-649, issn 0036-5521Article

Determinants of outcome of compensated hepatitis C virus-related cirrhosisSERFATY, L; AUMAITRE, H; CHAZOUILLERES, O et al.Hepatology (Baltimore, Md.). 1998, Vol 27, Num 5, pp 1435-1440, issn 0270-9139Article

Quels sont les modes de transmission non transfusionnels du virus de l'hépatite C ? = What are the extra transfusional modes of transmission of hepatitis C virus ?SERFATY, L; MAVIER, P; VALLA, D et al.Gastroentérologie clinique et biologique. 1995, Vol 19, Num 5, pp 525-533, issn 0399-8320Article

5èmes Rencontres de Psychogérontologie Clinique. Rennes - 16 et 17 novembre 2006. Les ActesMALO, P.Y; LE DOUJET, D; LABOUGLIE, V et al.5èmes Rencontres de Psychogérontologie Clinique. Rennes - 16 et 17 novembre 2006. Les Actes. 2006, 110 p.Conference Proceedings

Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancerPARC, Y; GUEROULT, S; MOURRA, N et al.Gut. 2004, Vol 53, Num 3, pp 371-375, issn 0017-5749, 5 p.Article

Association d'un syndrome de Gougerot-Sjögren et d'une hépatite virale C : à propos de 6 observations = Gougerot-Sjögren syndrome associated with hepatitis C: 6 case reportWATTIAUX, M.-J; JOUAN-FLAHAULT, C; YOUINOU, P et al.Annales de médecine interne (Paris). 1995, Vol 146, Num 4, pp 247-250, issn 0003-410XConference Paper

L'hépatite C = Hepatitis CGIRAL, P; SERFATY, L; LORIA, A et al.La Revue de médecine interne (Paris). 1994, Vol 15, Num 7, pp 487-493, issn 0248-8663Article